Teva Pharmaceutical Industries Comprehensive Income 2010-2024 | TEVA
Teva Pharmaceutical Industries comprehensive income for the quarter ending September 30, 2024 was $-2.769B, a 4.85% decline year-over-year.
- Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
- Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.
- Teva Pharmaceutical Industries comprehensive income for 2021 was $-2.683B, a 11.84% increase from 2020.